A cycle effect was identified with a significant decreased [177Lu]Lu-PSMA-I&T uptake in tumors in later cycles (dOFV −157), where the tumor uptake rate decreased to 73%, 50% and 44% uptake in cycle 2, 3 and 4–7 compared to cycle 1, respectively. The gene discussed is FOLH1; the disease is neoplasm.